• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

FDA rejects Mesoblast's cell therapy for bone marrow transplant complications

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 04, 2023 at 12:22: PM
via The U.S. Food and Drug Administration had rejected Mesoblast's cell therapy for children under 12 years of age for treating a type of complication that occurs after a stem cell or bone marrow transplant, the company said on Thursday.

article source
 




Top Bottom
Back
Quote